LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc. (LENZ) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
lenz · stock forecast · 5 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$12.00
Consensus
$12.00
+76.1% upside
Low
$12.00
Median: $12 · Last Close: $6.82
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $6.56 | ↓ 3.81% |
1-day model range: $6.39–$6.72. Peak: $6.72 (-3.81%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -4.3% |
| 2028 | — | -6.3% |
| 2029 | — | -7.3% |
| 2030 | — | -7.8% |
| 2031 | — | -8.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · LENZ · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Citigroup | Maintains | Buy→Buy |
| 2026-05-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-12 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2026-04-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-26 | Citigroup | Maintains | Buy→Buy |
| 2026-03-25 | B of A Securities | Maintains | Buy→Buy |
| 2025-10-20 | Raymond James | Maintains | Outperform→Outperform |
| 2025-10-10 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-08-01 | Citigroup | Maintains | Buy→Buy |
| 2025-08-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on LENZ Therapeutics, Inc. (LENZ) stock. Of the recent 20 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover LENZ.
Analyst Recommendation Trends
LENZ analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$19M
↓ 85.9% YoY
Revenue Next Year
$65M
↑ 238.9% YoY
EPS This Year
$-4.56
EPS Next Year
$-3.47
↓ 24.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast LENZ EPS of $-4.56 for the current fiscal year, based on estimates from 6 analysts. The LENZ revenue forecast is $19M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The LENZ stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LENZ price target is $12.00 (+76.1% upside), with an analyst consensus of Buy.
The LENZ short-term stock prediction for tomorrow is $6.56 (-3.81%). The LENZ stock prediction for 2030 projects a range of $6–$7.
LENZ Therapeutics, Inc. trades on NASDAQ under the ticker LENZ. The LENZ stock outlook for 2027 is broadly positive, supported by a Buy consensus among 80% of covering analysts.
Frequently asked questions
LENZ forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month LENZ price target is $12.00, with a high forecast of $12.00 and a low of $12.00. The median price target is shown in the chart above when available. This implies +76.1% potential upside from the current price of $6.82.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.